BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1308 related articles for article (PubMed ID: 24308063)

  • 61. Usefulness of KL-6 in the subtyping of intraductal papillary mucinous neoplasia of the pancreas, including carcinoma, dysplasia, and hyperplasia.
    Ohtsuki Y; Watanabe R; Kimura M; Nomura K; Maeda T; Kito K; Takeji M; Lee GH; Furihata M
    Med Mol Morphol; 2015 Jun; 48(2):85-91. PubMed ID: 24908068
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?
    Linder S; Holmberg M; Engstrand J; Ghorbani P; Sparrelid E
    Surg Oncol; 2022 May; 41():101735. PubMed ID: 35287096
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas.
    Murakami Y; Uemura K; Hayashidani Y; Sudo T; Sueda T
    J Gastrointest Surg; 2007 Mar; 11(3):338-44. PubMed ID: 17458608
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chronic Pancreatitis Finding by Endoscopic Ultrasonography in the Pancreatic Parenchyma of Intraductal Papillary Mucinous Neoplasms Is Associated with Invasive Intraductal Papillary Mucinous Carcinoma.
    Takenaka M; Masuda A; Shiomi H; Yagi Y; Zen Y; Sakai A; Kobayashi T; Arisaka Y; Okabe Y; Kutsumi H; Toyama H; Fukumoto T; Ku Y; Kudo M; Azuma T
    Oncology; 2017; 93 Suppl 1():61-68. PubMed ID: 29258092
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does a family history of pancreatic ductal adenocarcinoma and cyst size influence the follow-up strategy for intraductal papillary mucinous neoplasms of the pancreas?
    Mandai K; Uno K; Yasuda K
    Pancreas; 2014 Aug; 43(6):917-21. PubMed ID: 24743378
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognosis of invasive intraductal papillary mucinous neoplasm.
    Longnecker DS; Klöppel G
    Pancreas; 2008 Oct; 37(3):333; author reply 333-4. PubMed ID: 18815559
    [No Abstract]   [Full Text] [Related]  

  • 68. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of PD-L1 and VISTA in Intraductal Papillary Mucinous Neoplasm With Associated Invasive Carcinoma of the Pancreas.
    Mo S; Zou L; Hu Y; Chang X; Chen J
    Mod Pathol; 2023 Sep; 36(9):100223. PubMed ID: 37244388
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas.
    Nakagohri T; Konishi M; Inoue K; Tanizawa Y; Kinoshita T
    Hepatogastroenterology; 2004; 51(59):1480-3. PubMed ID: 15362782
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
    Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic relevance of pathologic subtypes and minimal invasion in intraductal papillary mucinous neoplasms of the pancreas.
    Kim J; Jang KT; Mo Park S; Lim SW; Kim JH; Lee KH; Lee JK; Heo JS; Choi SH; Choi DW; Rhee JC; Lee KT
    Tumour Biol; 2011 Jun; 32(3):535-42. PubMed ID: 21190101
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
    Lüttges J; Zamboni G; Longnecker D; Klöppel G
    Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel xenograft and cell line derived from an invasive intraductal papillary mucinous neoplasm of the pancreas give new insights into molecular mechanisms.
    Fritz S; Fernández-del Castillo C; Iafrate AJ; Mino-Kenudson M; Neyhard N; LaFemina J; Stirman A; Warshaw AL; Thayer SP
    Pancreas; 2010 Apr; 39(3):308-14. PubMed ID: 19924021
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas.
    Takahashi H; Nakamori S; Nakahira S; Tsujie M; Takahshi Y; Marubashi S; Miyamoto A; Takeda Y; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Ann Surg Oncol; 2006 Jul; 13(7):955-60. PubMed ID: 16788757
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.
    Mino-Kenudson M; Fernández-del Castillo C; Baba Y; Valsangkar NP; Liss AS; Hsu M; Correa-Gallego C; Ingkakul T; Perez Johnston R; Turner BG; Androutsopoulos V; Deshpande V; McGrath D; Sahani DV; Brugge WR; Ogino S; Pitman MB; Warshaw AL; Thayer SP
    Gut; 2011 Dec; 60(12):1712-20. PubMed ID: 21508421
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance.
    Kang MJ; Jang JY; Lee KB; Chang YR; Kwon W; Kim SW
    Ann Surg; 2014 Aug; 260(2):356-63. PubMed ID: 24378847
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms.
    Yamada S; Fujii T; Hirakawa A; Takami H; Suenaga M; Hayashi M; Niwa Y; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Pancreas; 2018 Sep; 47(8):974-979. PubMed ID: 30028445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.